ArticleFrontiers in microbiology2019
Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 132 citations in OpenAlex.
- Biocontrol potential of Burkholderia spp. against Fusarium oxysporum f. sp. lycopersici infecting tomato.Botanical studies · 2026Article
- Leaf penetration by endophytic Metarhizium brunneum enables infection of Phthorimaea absoluta in tomato mines while inducing the crop defense system.Pest management science · 2026Article
- Antifungal Activity and Genome Mining Reveal Potentiality of Streptomyces sp. VNUA24 as a Biocontrol Agent.The plant pathology journal · 2026Article
- Combined Mechanisms ofMicroorganisms · 2026Article
- Biofertilizer and Antifungal Potential ofPlants (Basel, Switzerland) · 2026Article
- Local and Systemic Transcriptional Responses of Tomato to a Growth-Promoting Streptomyces Consortium.Plants (Basel, Switzerland) · 2026Article
- Mechanistic insights and biotechnological applications of Streptomyces secondary metabolites in plant abiotic stress mitigation.World journal of microbiology & biotechnology · 2026Review
- Biocontrol ofFrontiers in plant science · 2026Article
- Antifungal properties of Eucalyptus endophytic Streptomyces strains.Scientific reports · 2025Article
- Streptomyces sp. JCK-7385 Effectively Controls Fusarium Head Blight in Rice and Wheat.The plant pathology journal · 2025Article
- In silico and in vitro analyses reveal the potential use of Streptomyces parvulus VNUA74 as bioagent for sustainable banana production.Scientific reports · 2025Article
- Control effects and mechanisms of metabolites fromFrontiers in plant science · 2025Article
- Antagonism ofFrontiers in microbiology · 2025Article
- Potential ofJournal of fungi (Basel, Switzerland) · 2024Article
- Exploration of a multifunctional biocontrol agent Streptomyces sp. JCK-8055 for the management of apple fire blight.Applied microbiology and biotechnology · 2024Article
- Bacillus endophytic strains control Fusarium wilt caused by Fusarium oxysporum f. sp. lycopersici in tomato cv. Perinha.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- An Algerian Soil-LivingJournal of fungi (Basel, Switzerland) · 2024Article
- Microbe-Friendly Plants Enable Beneficial Interactions with Soil Rhizosphere Bacteria by Lowering Their Defense Responses.Plants (Basel, Switzerland) · 2024Article
- Deciphering the role of rhizosphere microbiota in modulating disease resistance in cabbage varieties.Microbiome · 2024Article
- Oligomycin-producingmSphere · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant growth promoting rhizobacteria (PGPR) are potential natural alternatives to chemical fungicides in greenhouse production via inducing plant immune system against biotic stresses. In this research, 126
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.